Synonyms: 1-O-Octadecyl-2-O-benzyl-sn-glyceryl-3-phospho-GS-441524 | compound 5c [PMID: 34310217] | example 67 [WO2022081973A1] | ODBG-P-RVn
Compound class:
Synthetic organic
Comment: V2043 is an orally bioavailable phospholipid analogue of remdesivir nucleoside (RVn; GS-441524) [1,3]. It is a prodrug that is metabolised first to RVn monophosphate (by sphingomyelin phosphodiesterase I), and then to the active metabolite RVn triphosphate. Mechanistically, RVn triphosphate inhibits the viral RNA-dependent RNA polymerase (RdRP). Antiviral activity against SARS-CoV-2 has been demonstrated in vitro and in a mouse model of SARS-CoV-2 infection. Structural modifications of V2043 have been reported to improve its antiviral activity [1].
|
|
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel